Reports

Ideas That Generate Results

1. Analyst View

2. Research Methodology

3. In Vitro Diagnostic Market Overview
     3.1 Introduction
     3.2 What is In Vitro Diagnostics?
     3.3 Market Size and Growth

4. Clinical Segmentation Outlook 2018
     4.1 Point-of-Care Diagnostics
     4.2 Immunochemistry
     4.3 Clinical Chemistry
     4.4 Molecular Diagnostics
     4.5 Hematology
     4.6 Microbiology
     4.7 Hemostasis
     4.8 Immunohematology

5. Geographical Segmentation (Current & Future Scenario - 2018)
     5.1 America
            5.1.1 United States
            5.1.2 Canada
            5.1.3 Brazil
            5.1.4 Mexico
     5.2 Europe
            5.2.1 Germany
            5.2.2 France
            5.2.3 Italy
            5.2.4 United Kingdom
            5.2.5 Spain
     5.3 Asia-Pacific
            5.3.1 Japan
            5.3.2 China
            5.3.3 India

6. Industry Trends
     6.1 Fast Emerging Niche: Devices to Capture Circulating Tumor Cells
     6.2 On the Horizon: Non-Invasive Genetic Tests for Cancer
     6.3 Non-Invasive Prenatal Diagnostics Market Witnesses Boom
     6.4 Companion Diagnostics Partnerships Gear Up
     6.5 Predictive Cancer Diagnostic Test Market Rockets Northwards
     6.6 POCT: Expanding Avenues into Multiple Disease Diagnosis

7. Competitive Landscape
     7.1 Market Share of Top Players
     7.2 Key Players
            7.2.1 Abbott Laboratories
            7.2.2 Alere, Inc.
            7.2.3 Becton Dickinson
            7.2.4 Bayer HealthCare
            7.2.5 Beckman Coulter
            7.2.6 Biomerieux
            7.2.7 Johnson and Johnson
            7.2.8 Life Technologies Corporation
            7.2.9 Medtronic, Inc.
            7.2.10 Qiagen NV
            7.2.11 Roche Holding Ltd
            7.2.12 Sysmex Corporation
            7.2.13 Siemens HealthCare
            7.2.14 Thermo Fisher Scientific